SEC Filing Analysis: FACTSET RESEARCH SYSTEMS INC (FDS)

Executive Summary

• Trading Significance: Low
• Key Takeaway: FactSet's Chief Technology Officer was granted 6,969 stock options as part of a standard executive compensation plan.
• Market Impact: Neutral. This is a routine, non-market transaction with minimal potential dilution and does not signal a change in insider sentiment.

Company Information

Field	Value
Company	FACTSET RESEARCH SYSTEMS INC
Ticker Symbol	FDS
CIK	0001013237
Market Cap	$9.98 billion

Insider Information

Field	Value
Name	Stepp Katherine M
CIK	0001944065
Title/Position	Chief Technology Officer (CTO)
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-03
Transaction Code	A (Award)
Security Type	Employee Stock Option (right to buy)
Shares Involved	6,969
Price Per Share	$0.00
Total Value	$0
Shares Owned After	6,969 (Derivative securities)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	6,969
% of Shares Outstanding	0.018%
Post-Transaction Ownership	6,969 options (common stock holdings not specified)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $9.98 billion, this grant has no immediate market value and is considered a routine operational expense related to compensation.
• Ownership Concentration: This filing only reports the new option grant and does not provide a complete picture of the insider's total holdings in FactSet.
• Dilution Impact: The grant of 6,969 options represents a potential future dilution of just 0.018% of the 37,806,774 shares outstanding. This impact is negligible and well within normal operational parameters for executive compensation.
• Transaction Significance: The transaction is a non-cash award and represents less than 0.1% of shares outstanding, categorizing it as low significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a scheduled compensation grant, not an open-market transaction. It does not reflect a new investment decision by the insider and is a common practice for executive remuneration.

Volume & Sentiment

• Expected Volume Impact: None. The grant does not involve a market transaction.
• Sentiment Indicator: Neutral. The market generally views standard equity compensation for executives as a routine event.

Additional Context

Transaction Notes

• Vesting Schedule: The options vest 25% annually on the anniversary of the grant date and become fully vested after four years.
• Exercise Price: The options have an exercise price of $264.57 and an expiration date of 2035-11-03.